Literature DB >> 29671516

Vaginitis: Diagnosis and Treatment.

Heather L Paladine1, Urmi A Desai1.   

Abstract

Vaginitis is defined as any condition with symptoms of abnormal vaginal discharge, odor, irritation, itching, or burning. The most common causes of vaginitis are bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis. Bacterial vaginosis is implicated in 40% to 50% of cases when a cause is identified, with vulvovaginal candidiasis accounting for 20% to 25% and trichomoniasis for 15% to 20% of cases. Noninfectious causes, including atrophic, irritant, allergic, and inflammatory vaginitis, are less common and account for 5% to 10% of vaginitis cases. Diagnosis is made using a combination of symptoms, physical examination findings, and office-based or laboratory testing. Bacterial vaginosis is traditionally diagnosed with Amsel criteria, although Gram stain is the diagnostic standard. Newer laboratory tests that detect Gardnerella vaginalis DNA or vaginal fluid sialidase activity have similar sensitivity and specificity to Gram stain. Bacterial vaginosis is treated with oral metronidazole, intravaginal metronidazole, or intravaginal clindamycin. The diagnosis of vulvovaginal candidiasis is made using a combination of clinical signs and symptoms with potassium hydroxide microscopy; DNA probe testing is also available. Culture can be helpful for the diagnosis of complicated vulvovaginal candidiasis by identifying nonalbicans strains of Candida. Treatment of vulvovaginal candidiasis involves oral fluconazole or topical azoles, although only topical azoles are recommended during pregnancy. The Centers for Disease Control and Prevention recommends nucleic acid amplification testing for the diagnosis of trichomoniasis in symptomatic or high-risk women. Trichomoniasis is treated with oral metronidazole or tinidazole, and patients' sex partners should be treated as well. Treatment of noninfectious vaginitis should be directed at the underlying cause. Atrophic vaginitis is treated with hormonal and nonhormonal therapies. Inflammatory vaginitis may improve with topical clindamycin as well as steroid application.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29671516

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  26 in total

1.  Vaginal discharge: evaluation and management in primary care.

Authors:  Michelle Sim; Susan Logan; Lay Hoon Goh
Journal:  Singapore Med J       Date:  2020-06       Impact factor: 1.858

2.  Rapid differential diagnosis of vaginal infections using gold nanoparticles coated with specific antibodies.

Authors:  Hossein Hashemi; Jaleh Varshosaz; Hossein Fazeli; Seyedeh Maryam Sharafi; Hossein Mirhendi; Mostafa Chadeganipour; HosseinAli Yousefi; Kourosh Manoochehri; Zahra Aliyari Chermahini; Lobat Jafarzadeh; Nafiseh Dehghanisamani; Parvin Dehghan; Hossein Yousofi Darani
Journal:  Med Microbiol Immunol       Date:  2019-06-10       Impact factor: 3.402

3.  Association Between Common Vaginal Infections and Cervical Non-Human Papillomavirus (HPV) 16/18 Infection in HPV-Vaccinated Women.

Authors:  Shang-Ying Hu; Sabrina H Tsang; Feng Chen; Qin-Jing Pan; Wen-Hua Zhang; Ying Hong; Joshua N Sampson; Allan Hildesheim; Fang-Hui Zhao; Aimée R Kreimer
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

4.  Molecular Diagnosis of Vaginitis: Comparing Quantitative PCR and Microbiome Profiling Approaches to Current Microscopy Scoring.

Authors:  Tarah Lynch; Gisele Peirano; Tracie Lloyd; Ron Read; Julia Carter; Angel Chu; Jeffrey A Shaman; Joseph P Jarvis; Evan Diamond; Umer Zeeshan Ijaz; Deirdre Church
Journal:  J Clin Microbiol       Date:  2019-08-26       Impact factor: 5.948

5.  Real-world effectiveness and tolerability of Zelesse cream® for treating vulvovaginitis in adult women: an observational, prospective study.

Authors:  Ana Rosa Masero; Luís Manuel San Frutos; Ernesto Vizcaíno; María Palma; Syra Velasco-Ortega; Concepción Nieto
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

6.  Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.

Authors:  Do Ngoc Anh; Dao Nguyen Hung; Tran Viet Tien; Vu Nhat Dinh; Vu Tung Son; Nguyen Viet Luong; Nguyen Thi Van; Nguyen Thi Nhu Quynh; Nguyen Van Tuan; Le Quoc Tuan; Nguyen Duy Bac; Nguyen Khac Luc; Le Tran Anh; Do Minh Trung
Journal:  BMC Infect Dis       Date:  2021-06-03       Impact factor: 3.090

7.  Brazilian Protocol for Sexually Transmitted Infections, 2020: infections causing vaginal discharge.

Authors:  Newton Sergio de Carvalho; José Eleutério Junior; Ana Gabriela Travassos; Lutigardes Bastos Santana; Angélica Espinosa Miranda
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

8.  Effects of vaginal microbiota and cervical cerclage on obstetric outcomes of twin pregnancies with cervical incompetence: a retrospective study.

Authors:  Xuan Zhou; Xiao-Xue Li; Yi-Meng Ge; Shao-Yang Lai; Luo-Qi Zhou; Ling Feng; Jie Zhao
Journal:  Arch Gynecol Obstet       Date:  2021-08-05       Impact factor: 2.344

Review 9.  Role of Vaginal Microbiota Dysbiosis in Gynecological Diseases and the Potential Interventions.

Authors:  Yiwen Han; Zhaoxia Liu; Tingtao Chen
Journal:  Front Microbiol       Date:  2021-06-18       Impact factor: 5.640

10.  Evaluating the accuracy and diagnostic value of CFW and a new fluorescent reagents, fluorescent brightener 85, for the diagnosis of vulvovaginal candidiasis.

Authors:  Yunzhuan Zhao; Zixuan Yu; Xueping Yue
Journal:  J Clin Lab Anal       Date:  2021-07-12       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.